Company intelligence / Profile preview

Reliant AI

Montreal, Quebec, Canadareliant.ai ↗

Ownership: Private
Development stage: Other

Overview

Reliant AI has developed and commercialized "Reliant Tabular," an advanced generative AI-powered data analysis platform tailored to accelerate secondary research, competitive intelligence, systematic literature reviews, and pipeline analysis within biopharma. It enables users to analyze both structured and unstructured scientific data rapidly—reportedly up to ten times faster than manual or general-purpose solutions—while maintaining high accuracy. The system indexes over 38 million publications, abstracts, and clinical trials. It has been recognized among CB Insights' "AI 100" most innovative startups of 2025.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Reliant AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reliant AI.

Explore the full profile